Conaway Darcy G, Sullivan Robbie, McCullough Peter A
University of Missouri-Kansas City and MidAmerica Heart Institute, St. Luke's Hospital, Kansas City, Missouri, USA.
Rev Cardiovasc Med. 2004 Winter;5(1):53-7.
This report examines the impact of resynchronization therapy in a patient with class IV heart failure and a prolonged QRS duration on electrocardiogram. The Kansas City Cardiomyopathy Questionnaire (KCCQ) was used to assess the patient's health status prior to, immediately after, and 2 months after placement of a biventricular pacemaker. B-type natriuretic peptide (BNP) values and electrocardiogram QRS duration were recorded to further document clinical status. Our patient experienced statistically significant improvements in 7 of 10 KCCQ domains after resynchronization. QRS duration narrowed following the procedure and BNP values decreased. Resynchronization therapy improved this patient's symptoms, physical limitations, and self-efficacy when maximal medical therapy failed.
本报告探讨了再同步治疗对一名IV级心力衰竭且心电图QRS时限延长患者的影响。采用堪萨斯城心肌病问卷(KCCQ)评估患者在植入双心室起搏器之前、之后即刻以及2个月后的健康状况。记录B型利钠肽(BNP)值和心电图QRS时限以进一步记录临床状态。我们的患者在再同步治疗后,KCCQ的10个领域中有7个领域出现了具有统计学意义的改善。术后QRS时限变窄,BNP值下降。当最大药物治疗无效时,再同步治疗改善了该患者的症状、身体限制和自我效能。